163 related articles for article (PubMed ID: 1439123)
1. Immunotherapeutic approaches with monoclonal antibodies to immunological diseases.
Cozzi E; Ferrone S
Recenti Prog Med; 1992 Sep; 83(9):528-33. PubMed ID: 1439123
[TBL] [Abstract][Full Text] [Related]
2. [New strategies in the immunotherapy of autoimmune diseases].
Lorenz HM; Geiler T
Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
[No Abstract] [Full Text] [Related]
3. Immunology. Gently soothing a savage immune system.
Couzin J
Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
[No Abstract] [Full Text] [Related]
4. Monoclonal antibodies in immune and inflammatory diseases.
Andreakos E; Taylor PC; Feldmann M
Curr Opin Biotechnol; 2002 Dec; 13(6):615-20. PubMed ID: 12482523
[TBL] [Abstract][Full Text] [Related]
5. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutics of multiple sclerosis.
Durelli L
Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy in autoimmune diseases: challenges and opportunities.
Leung PS; Dhirapong A; Wu PY; Tao MH
Autoimmun Rev; 2010 Jan; 9(3):170-4. PubMed ID: 19854300
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of the immune response in autoimmune demyelination.
Oksenberg JR
West J Med; 1994 Sep; 161(3):255-9. PubMed ID: 7975563
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3 antibodies.
Chatenoud L; Bach JF
Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
[No Abstract] [Full Text] [Related]
10. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
Wauben MH
Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
[TBL] [Abstract][Full Text] [Related]
11. CD20: a target antigen for immunotherapy of autoimmune diseases.
Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
[TBL] [Abstract][Full Text] [Related]
12. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
[TBL] [Abstract][Full Text] [Related]
13. [New immunologic treatment of rheumatoid arthritis].
Sany J
Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
Quagliata F; Schenkelaars EJ; Ferrone S
Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
[No Abstract] [Full Text] [Related]
15. Receptor-targeted immunotherapy.
Janson RW; Arend WP
Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis and treatment of rheumatoid arthritis.
Lipsky PE
J Rheumatol Suppl; 1992 Jan; 32():92-4. PubMed ID: 1613739
[TBL] [Abstract][Full Text] [Related]
17. [New treatments of rheumatoid arthritis for future use].
Cantagrel A; Mazières B
Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
[TBL] [Abstract][Full Text] [Related]
18. Development of antigen-specific therapies for autoimmune disease.
Steinman L
Mol Biol Med; 1990 Aug; 7(4):333-9. PubMed ID: 2233245
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory autoimmune diseases with ablative immunotherapy.
Cohen Y; Nagler A
Autoimmun Rev; 2004 Feb; 3(2):21-9. PubMed ID: 15003184
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy in non-allergic diseases].
Español T
Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
